Related Experiment Video
Updated: Aug 2, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Indomethacin treatment of pericarditis in chronic hemodialysis patients
Insights
Indomethacin effectively treats symptomatic pericarditis in hemodialysis patients, reducing the need for invasive procedures like pericardiocentesis. Early treatment and continued use are key for symptom relief and preventing recurrence.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Symptomatic pericarditis is a complication of maintenance hemodialysis.
- Conventional treatments and pericardiectomy are often required.
- Dialysis-associated pericarditis can be challenging to manage.
Purpose of the Study:
- To evaluate the efficacy of indomethacin in treating symptomatic pericarditis in hemodialysis patients.
- To compare indomethacin treatment with other conventional measures.
- To determine if indomethacin can prevent the need for invasive procedures.
Main Methods:
- A cohort of 11 hemodialysis patients with symptomatic pericarditis was studied.
- Eight patients received indomethacin treatment.
- Treatment response, need for pericardiocentesis, and recurrence rates were monitored.
Main Results:
- Indomethacin led to rapid defervescence and pain relief within 6-24 hours in eight patients.
- Only one patient receiving indomethacin required pericardiocentesis.
- Symptoms recurred upon discontinuation of indomethacin within the first week.
- Dosage could be tapered after 3 weeks to 4 months of treatment.
Conclusions:
- Indomethacin is effective for treating dialysis-associated pericarditis.
- Indomethacin can preclude the need for invasive procedures like pericardiocentesis.
- Sustained treatment is necessary to prevent symptom recurrence.
Abstract:
Symptomatic pericarditis occurs in the course of maintenance hemodialysis and often requires pericardiectomy in addition to other conventional measures. Three of 11 such patients were treated with frequent dialysis and general supportive treatment. Two of these required pericardiocentesis. The other eight received indomethacin; this was followed by prompt defervescence and abatement of pain within 6 to 24 hours. Only one patient required pericardiocentesis. On every occasion when treatment was discontinued during the first week, symptoms recurred. After three weeks to four months, the drug dosage could be tapered and discontinued. The pericardial aspirate was hemorrhagic in all three patients who required pericardiocentesis. Indomethacin appears to be effective in the treatment of the pericarditis associated with dialysis and precludes the need for invasive procedures.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Hemodialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care

